A Multiplexed Digital Platform Enables Detection of Attomolar Protein Levels with Minimal Cross-Reactivity
Protein-based biomarkers are essential for disease diagnostics, yet their low abundance in biofluids often presents significant detection challenges for traditional enzyme-linked immunosorbent assay (ELISA) techniques. While various ultrasensitive methods such as digital ELISA have improved sensitivity, multiplex assays still suffer from considerable cross-reactivities that can compromise result accuracies. To address this challenge, we have developed barcoded Molecular On-bead Signal Amplification for Individual Counting (barcoded MOSAIC), a multiplexed digital ELISA technology that markedly reduces cross-reactivity by pairing barcoded detection antibodies with specific bead types. This approach enables the simultaneous detection of eight analytes from less than 9 μL of blood, with sensitivities ranging from midpicomolar to low-attomolar levels and a collective dynamic range exceeding seven logs across multiple analytes within a single multiplex assay. Additionally, barcoded MOSAIC is compatible with standard immunoassay reagents and workflows, utilizing a rapid, automatable flow cytometric readout for quantification, which makes it a highly accessible benchtop platform that is readily adoptable by both research and clinical laboratories, setting the stage for future translation into point-of-care applications.
Authors
- Stephanie J. Zhang (ORCID: https://orcid.org/0000-0001-6308-5257)
- Connie Wu
- David R. Walt (ORCID: https://orcid.org/0000-0002-5524-7348)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Harvard University Press (US)
- Inspire (CH)
Publication Details
- Journal
- ACS Nano
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1021/acsnano.4c10340
- Citations
- 27
- Primary Topic
- Advanced Biosensing Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 6.31
Funders
- National Institute of Biomedical Imaging and Bioengineering